Insider Trading Alert - KMG, AER And ENDP Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, June 18, 2015, 71 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $77.50 to $28,170,000.00.

Highlighted Stocks Traded by Insiders:

KMG Chemicals (KMG) - FREE Research Report

Hatcher David L, who is 10% Owner at KMG Chemicals, sold 3,000 shares at $28.70 on June 18, 2015. Following this transaction, the 10% Owner owned 1.9 million shares meaning that the stake was reduced by 0.16% with the 3,000-share transaction.

The shares most recently traded at $28.69, down $0.01, or 0.05% since the insider transaction. Historical insider transactions for KMG Chemicals go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 24,000
  • 12-Week # shares bought: 3,000
  • 12-Week # shares sold: 73,500
  • 24-Week # shares bought: 3,000
  • 24-Week # shares sold: 78,500

The average volume for KMG Chemicals has been 86,700 shares per day over the past 30 days. KMG Chemicals has a market cap of $333.2 million and is part of the basic materials sector and chemicals industry. Shares are up 42.55% year-to-date as of the close of trading on Thursday.

KMG Chemicals, Inc., through its subsidiaries, engages in the manufacture, formulation, and distribution of specialty chemicals in the United States, Mexico, Canada, Europe, Israel, and Singapore. It operates in two segments, Electronic Chemicals and Wood Treating Chemicals. The stock currently has a dividend yield of 0.42%. The company has a P/E ratio of 42.5. Currently, there is 1 analyst who rates KMG Chemicals a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KMG - FREE

TheStreet Quant Ratings rates KMG Chemicals as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, expanding profit margins, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and impressive record of earnings per share growth. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full KMG Chemicals Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

AerCap Holdings (AER) - FREE Research Report

Gradon Michael, who is Director at AerCap Holdings, sold 1,603 shares at $46.41 on June 18, 2015. Following this transaction, the Director owned 592 shares meaning that the stake was reduced by 73.03% with the 1,603-share transaction.

The shares most recently traded at $46.69, up $0.28, or 0.61% since the insider transaction. Historical insider transactions for AerCap Holdings go as follows:

  • 4-Week # shares sold: 25,000
  • 12-Week # shares sold: 25,000
  • 24-Week # shares sold: 25,000

The average volume for AerCap Holdings has been 2.2 million shares per day over the past 30 days. AerCap Holdings has a market cap of $10.0 billion and is part of the services sector and transportation industry. Shares are up 20.71% year-to-date as of the close of trading on Thursday.

AerCap Holdings N.V., an independent aircraft leasing company, engages in the leasing, financing, sale, and management of commercial aircraft and engines. The company has a P/E ratio of 8.5. Currently, there are 7 analysts who rate AerCap Holdings a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AER - FREE

TheStreet Quant Ratings rates AerCap Holdings as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we find that the company has favored debt over equity in the management of its balance sheet. Get the full AerCap Holdings Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Endo International (ENDP) - FREE Research Report

Higgins Arthur J, who is Director at Endo International, bought 2,500 shares at $81.10 on June 18, 2015. Following this transaction, the Director owned 22,771 shares meaning that the stake was boosted by 12.33% with the 2,500-share transaction.

The shares most recently traded at $83.82, up $2.72, or 3.25% since the insider transaction. Historical insider transactions for Endo International go as follows:

  • 12-Week # shares bought: 5,478
  • 12-Week # shares sold: 8,650
  • 24-Week # shares bought: 3,700
  • 24-Week # shares sold: 14,450

The average volume for Endo International has been 2.4 million shares per day over the past 30 days. Endo International has a market cap of $14.4 billion and is part of the health care sector and drugs industry. Shares are up 11.9% year-to-date as of the close of trading on Thursday.

Endo International plc, a specialty healthcare company, focuses on branded and generic pharmaceuticals and devices worldwide. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices, and International Pharmaceuticals. The U.S. Currently, there are 9 analysts who rate Endo International a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ENDP - FREE

TheStreet Quant Ratings rates Endo International as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Endo International Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Facebook, Apple and Alphabet Are Actually Cheap Here, Jim Cramer Says

Facebook, Apple and Alphabet Are Actually Cheap Here, Jim Cramer Says

The Stock Market Isn't Stupid High: Market Recon

The Stock Market Isn't Stupid High: Market Recon

Insider Trading Alert - KMG, FSIC And HA Traded By Insiders

Insider Trading Alert - KMG, FSIC And HA Traded By Insiders

Insider Trading Alert - KMG, TCPC And WDC Traded By Insiders

Insider Trading Alert - KMG, TCPC And WDC Traded By Insiders

Insider Trading Alert - KMG, EGP, And MUX Traded By Insiders

Insider Trading Alert - KMG, EGP, And MUX Traded By Insiders